Peter A. Milligan
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 3
-
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Mats O. Karlsson (7 shared papers)Irja Lutsar (3 shared papers)Nolan Wood (2 shared papers)Antonio Arrieta (2 shared papers)Thomas J. Walsh (2 shared papers)Timothy Driscoll (2 shared papers)R L Lalonde (2 shared papers)Ulrika Wählby (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Pharmacokinetics and Pharmacodynamics (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Peter A. Milligan
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 119
- Statistics and Probability 231
- Infectious Diseases 476
- Pharmacology 136
- Pharmacology 174
- Epidemiology 311
Countries citing papers authored by Peter A. Milligan
This map shows the geographic impact of Peter A. Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Milligan more than expected).
Fields of papers citing papers by Peter A. Milligan
This network shows the impact of papers produced by Peter A. Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Milligan. The network helps show where Peter A. Milligan may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Milligan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 302 | |
| 2 | 2004 | 247 | |
| 3 | 2013 | 175 | |
| 4 | 2008 | 167 | |
| 5 | 2010 | 101 | |
| 6 | 2004 | 58 | |
| 7 | 2002 | 55 | |
| 8 | 2003 | 42 | |
| 9 | 1992 | 30 | |
| 10 | 2003 | 25 | |
| 11 | 2015 | 21 | |
| 12 | 2009 | 11 | |
| 13 | 2007 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2023 | 10 | |
| 16 | 2008 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2020 | 6 | |
| 19 | 1993 | 5 | |
| 20 | 2016 | 4 |
About Peter A. Milligan
Peter A. Milligan is a scholar working on Infectious Diseases, Pharmacology, Pulmonary and Respiratory Medicine, Epidemiology and Pharmacology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Fungal Infections and Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Computational Drug Discovery Methods (2 papers), Pharmaceutical Economics and Policy (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Statistics and Probability (231 citations), Infectious Diseases (476 citations), Pharmacology (136 citations), Pharmacology (174 citations) and Epidemiology (311 citations). Peter A. Milligan has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Mats O. Karlsson, Irja Lutsar, Nolan Wood, Antonio Arrieta, Thomas J. Walsh, Timothy Driscoll, R L Lalonde, Ulrika Wählby, Jeffrey L. Blumer and Xavier Sáez‐Llorens. Their work appears in journals such as British Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, Cancer Chemotherapy and Pharmacology and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.